Outsourcing Clinical Trials Israel 2020
In light of the recent global developments around the COVID-19 virus, and action taken by the Israeli government, we have made the unavoidable decision to postpone Outsourcing in Clinical Trials Israel 2020 in Tel Aviv.
Israel is, as well as restricting entries from specific countries, banning any international travellers from attending gatherings of 100 people or more. Whilst the majority of our audience are local, there are significant numbers travelling internationally, as well as the Arena International organising team, who are now unable to enter Israel for the purpose of this event. The full guidance is available here, in English: https://govextra.gov.il/ministry-of-health/corona/corona-virus-en/
Whilst there is no suggestion Israel is actually dangerous to travel to, we must comply with these restrictions, and fully recognise that amending the event to be hosted without the international contingent would be in nobody's best interests.
We would like to be clear that this is a postponement, and not a cancellation, and we look forward to hosting OCT Israel later in 2020.
We will be announcing our new dates within the next four weeks.
We appreciate your support and understanding of this unavoidable course of action.
WHAT TO EXPECT FOR 2020?
The meeting place for healthcare pioneers and innovators
Join local Israeli pharmaceutical, medical device and biotech experts to discuss new trends and opportunities, learn how to optimize clinical operations and find the right solution providers to partner with to accelerate your trial timelines
ATTENDEES AT DIRECTOR+ LEVEL
This is an exceptional networking opportunity for industry accelerators. Meet industry C-Suite and Director level executives from leading pharma like TEVA, Janssen and Roche and local biotechs to make valuable connections at this annual gathering
Join like-minded peers to learn new perspectives and case studies such as global site management, clinical trial management for rare diseases, packaging and labeling processes and hear success stories from medical device start ups.
The conference discusses the vital connections between process, tools and techniques to manage change. Update your knowledge to create new strategies enabling you to enact change within your clinical trials
Catalent solves today’s clinical trial challenges and develop innovative solutions for the future. Catalent’s commitment to quality and service excellence is evident in its flexible solutions, modern global facilities, and over 25 years’ experience reliably supplying thousands of studies of all sizes and complexities around the world.
Alderley Analytical Ltd is an independent UK-based laboratory providing a bioanalytical service. We are GLP and GCP compliant and have the expertise to perform regulatory bioanalysis to support the pharmacokinetic endpoint for your clinical studies.
The team at Alderley Analytical have a wealth of experience from working in large Pharma companies and CRO’s, ensuring that we deliver the right science, on-time to meet your budget.
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Employing over 21,000 people worldwide, we are the world’s most comprehensive CRO, dedicated to improving health and improving lives. www.covance.com.
Syneos Health (Nasdaq:SYNH*) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit SyneosHealth.com.
Pharm-Olam International delivers cost effective, quality clinical services to pharma and biotech sponsors across all therapeutic areas in more than 40 countries. Since 1994, we have been committed to our objective: to create value for our clients by satisfying their clinical development needs with consistent and dependable solutions and services.